myFibroScan vs Breezing Pro
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
myFibroScan
This app assists healthcare professionals in interpreting FibroScan® results for liver health management. It provides tools and scores based on clinical studies to aid in assessing liver disease and identifying at-risk patients.
- Interpretation Guide for FibroScan® results
- FibroScan® based scores for liver disease assessment
- Fast score for MASH patient risk identification
- Agile 3+ score for advanced fibrosis identification
- Agile 4 score for cirrhosis identification
- MASH Treatment Eligibility Tool
Read full descriptionHide full description
FibroScan® is the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is powered by three unique, patented and validated biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 5300+ peer-reviewed publications and 180+ international guidelines. myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way : The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting FibroScan® examination results. Scores enhance FibroScan® liver disease assessment with biological markers. Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions. • Fast is an aid to identify at risk MASH patients defined as MASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (MASLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast. • Agile 3+ is an aid to identify MASLD patients with advanced fibrosis by combining LSM by VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins. • Agile 4 is an aid to early identify MASLD patients with cirrhosis by combining LSM by VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin. MASH Treatment Eligibility Tool to eliminate the Guesswork. This patient management tool embeds treatment recommendations based on the patient’s FibroScan® results and the latest AASLD Guidance.
Breezing Pro
Read full descriptionHide full description
** You must have a Breezing Pro mask device to utilize this app as intended ** Breezing Pro is a connected wearable device that provides gold-standard indirect calorimetry for the precise measurement of resting energy expenditure (REE) and respiratory quotient (RQ). The Breezing Pro mobile app connects to the Breezing Pro device over a secure Bluetooth connection to provide step-by-step guidance for each test, and to present and track patient-level results. Breezing Pro is designed specifically for healthcare professionals to measure REE and RQ data to better personalize nutritional and lifestyle programs and help patients achieve their desired goals more quickly and reliably. How will Breezing Pro help your patients succeed and achieve their goals? Stop Guessing Accurate REE measurement is an essential ingredient to personalize weight management programs for the unique needs of each patient. Predictive metabolic equations are inaccurate by more than 10% for 3 out of 4 individuals and can overestimate or underestimate your patient’s resting metabolic rate by nearly 1,000kCal/day. Other devices on the market intended to measure REE are cumbersome and expensive to use. Breezing Pro is the only wearable metabolic assessment device that is cost effective and simple enough to fit into existing patient workflows, and delivers the gold-standard precision necessary for predictable, successful results. Start Measuring The Academy of Nutrition and Dietetics recommends the measurement of energy expenditure by means of indirect calorimetry when determining an individual’s caloric needs. Breezing Pro provides gold standard indirect calorimetry by measuring both V02 andVC02. The accuracy of measured indirect calorimetry with Breezing Pro allows for building a weight management plan you and your patients can trust will work from the start. Inspire Adherence Individuals using Breezing, while following a structured weight management plan, showed 70% greater adherence and 3x greater weight loss compared to a control group using predictive equations. Breezing Pro, with its associated mobile application, provides the additional motivation your weight management patients need. With Breezing Pro mobile app, you can: • Create and manage your patient profiles • Perform REE measurements with our proprietary Breezing Pro mask device following step-by-step guidance prompted by the app • Track historical results to monitor progress over time, and to compare trends for key variables measured in each test • Print, export and securely share results data with your team or with your patients Users must seek a doctorʼs advice before making any medical decisions.
Screenshots
Verdict
The clearest difference is iOS requirement: Breezing Pro at 13.0 against myFibroScan's 15.6. On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
myFibroScan ships an update every 8 months, Breezing Pro every 13 months. The most recent releases landed on September 16, 2026 and September 21, 2026 respectively.
| Parameter | myFibroScan | Breezing Pro |
|---|---|---|
| Price | Free | Free |
| Rating | 3.0 (4 ratings) — better | — |
| Positive reviews | 0.0% of reviews | — |
| Number of ratings | 4 — better | — |
| Update frequency | Every 8 months — better | Every 13 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Ad-supported | — |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.6 | 13.0 — better |
| Further details — not scored | ||
| Size | 40 MB | 40 MB |
| Age rating | 17+ | 4+ |
| Developer | ECHOSENS | TF Health Corporation |
In-app purchases
myFibroScan
No in-app purchases
Breezing Pro
No in-app purchases








